Recovery of contractile function in post-ischaemic reperfused myocardium of conscious dogs: influence of nicorandil, a new antianginal agent
- PMID: 2947685
- DOI: 10.1093/cvr/20.8.621
Recovery of contractile function in post-ischaemic reperfused myocardium of conscious dogs: influence of nicorandil, a new antianginal agent
Abstract
The effects of intravenous administration of nicorandil, a new antianginal agent, on the recovery of regional myocardial contractile function after a 10 minute coronary artery occlusion were studied in chronically instrumented conscious dogs. Compared with the control group nicorandil administration resulted in an increase in heart rate and a decrease in blood pressure with an overall increase in the double product during the preocclusion period, no significant difference in double product during ischaemia, and a significant decrease in double product during reperfusion. After reperfusion the return of regional contractile function was appreciably enhanced in the nicorandil treated group. These effects were seen immediately after coronary reflow and persisted throughout the reperfusion period. These data suggest that nicorandil protects ischaemic cardiac tissue, and that the beneficial actions may be mediated through a reduction in left ventricular afterload.
Similar articles
-
Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine.J Cardiovasc Pharmacol. 1985 Jan-Feb;7(1):158-66. doi: 10.1097/00005344-198501000-00026. J Cardiovasc Pharmacol. 1985. PMID: 2580137
-
Comparative effects of nicorandil, nitroglycerin, nicotinic acid, and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium.J Cardiovasc Pharmacol. 1987;10 Suppl 8:S76-84. J Cardiovasc Pharmacol. 1987. PMID: 2447429
-
Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia.Eur J Pharmacol. 1996 Jun 3;305(1-3):163-8. doi: 10.1016/0014-2999(96)00166-5. Eur J Pharmacol. 1996. PMID: 8813547
-
Acute hemodynamic effects of nicorandil in coronary artery disease.J Cardiovasc Pharmacol. 1992;20 Suppl 3:S52-6. doi: 10.1097/00005344-199206203-00010. J Cardiovasc Pharmacol. 1992. PMID: 1282176 Review.
-
Effects of nicorandil on coronary circulation and myocardial ischemia.Am J Cardiol. 1989 Jun 20;63(21):11J-17J. doi: 10.1016/0002-9149(89)90199-9. Am J Cardiol. 1989. PMID: 2525319 Review.
Cited by
-
A cell-based phenotypic assay to identify cardioprotective agents.Circ Res. 2012 Mar 30;110(7):948-57. doi: 10.1161/CIRCRESAHA.111.263715. Epub 2012 Mar 6. Circ Res. 2012. PMID: 22394516 Free PMC article.
-
Left ventricular effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs.Cardiovasc Drugs Ther. 1990 Dec;4(6):1449-54. doi: 10.1007/BF02026490. Cardiovasc Drugs Ther. 1990. PMID: 2150492
-
Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits.Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1273-80. doi: 10.1152/ajpheart.01055.2003. Epub 2003 Dec 18. Am J Physiol Heart Circ Physiol. 2004. PMID: 14684373 Free PMC article.
-
Effect of the potassium-channel opener nicorandil as an adjunct to cardioplegia on myocardial preservation in isolated rabbit hearts.Surg Today. 1996;26(10):782-92. doi: 10.1007/BF00311637. Surg Today. 1996. PMID: 8897676
-
Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil.Cardiovasc Drugs Ther. 1992 Jun;6(3):225-32. doi: 10.1007/BF00051143. Cardiovasc Drugs Ther. 1992. PMID: 1322163
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources